Homocysteine: the predictor nobody knows that tells you about your future.
An amino acid that doubles stroke and dementia risk. Costs almost nothing to measure. Almost never in a standard checkup.
There is a test that doubles as a forecast. Homocysteine (an amino acid that forms when the body processes methionine from dietary protein) is one of the most clinically powerful predictors of long term cardiovascular and cognitive risk. It is cheap, easily measured, and almost never included in a standard checkup.
What elevated homocysteine does.
When homocysteine is properly metabolised, it is quickly recycled into harmless molecules. This recycling requires three B vitamins: B12, folate, and B6. If any of these is insufficient, homocysteine accumulates, and elevated homocysteine is toxic to the vascular endothelium, the single cell layer lining every blood vessel in your body.
The clinical evidence is substantial. A meta analysis published in JAMA covering 30 studies and over 5,000 patients found that for every 5 μmol/L increase in homocysteine, the risk of coronary artery disease rose by 20% in women and 32% in men. A separate analysis found that homocysteine above 10 μmol/L doubled ischaemic stroke risk.
Homocysteine is an early warning system that works 10 to 20 years before symptoms. Most people who test it for the first time discover they have been carrying elevated levels for years.
Cognitive risk.
The evidence connecting homocysteine to dementia is now robust. A review in the Journal of Alzheimer's Disease concluded that elevated homocysteine is one of the strongest modifiable risk factors for cognitive decline. The Oxford VITACOG randomised trial found that B vitamin supplementation reduced brain atrophy by 73% in people with elevated homocysteine at baseline.
Seventy three percent.
What the ranges mean.
- Below 7 μmol/L: optimal.
- 7 to 10 μmol/L: borderline. Worth addressing.
- 10 to 15 μmol/L: mildly elevated. Active intervention recommended.
- Above 15 μmol/L: significantly elevated. Cardiovascular risk is meaningfully increased.
Italian labs typically flag homocysteine as abnormal only above 15 μmol/L. The research suggests the risk slope begins at 10, and the optimal range is well below what most labs call normal.
What you can actually do about it.
Elevated homocysteine almost always responds to supplementation with methylfolate, methylcobalamin (B12), and pyridoxal 5 phosphate (active B6). Most people normalise within 90 days. The VITACOG trial used just 0.8mg folate, 0.5mg B12, and 20mg B6.
One test. One course of supplements. Potentially decades of reduced risk.
